Introduction <p>Overweight and obesity have been steadily increasing worldwide. Metabolic/bariatric surgery (MBS) is the most effective treatment for obesity and its associated medical conditions. Obesity complications increase with age, however, older patients face a higher perioperative risk necessitating a clear risk-benefit balance. This study evaluated weight-loss outcomes, remission of associated medical conditions, and complications in patients aged ≥ 65 years undergoing MBS.</p> Methods <p>This retrospective analysis included patients aged ≥ 65 years who underwent MBS at the Medical University of Vienna between 2008 and 2025. Weight and associated medical complications were assessed at baseline and at 1, 2, and 5 years postoperatively. Early (&lt; 30 days) and late complications up to 5 years were recorded. </p> Results <p>In total, 111 patients were included. Baseline weight was 125.8 ± 22.3&#xa0;kg and BMI 45.2 ± 7.4&#xa0;kg/<InlineEquation ID="IEq1"> <EquationSource Format="TEX">\(\:{\text{m}}^{2}\)</EquationSource> </InlineEquation>. At 5 years, mean BMI decreased to 27.5 ± 6.2&#xa0;kg/<InlineEquation ID="IEq2"> <EquationSource Format="TEX">\(\:{\text{m}}^{2}\)</EquationSource> </InlineEquation> corresponding to a total weight loss of 37.3 ± 14.7%. The prevalence of type II diabetes decreased from 54.1% to 22.9% and arterial hypertension from 87.4% to 56.2%. Early and late complications each occurred in 7.2%.</p> Conclusion <p>MBS achieves substantial long-term weight reduction and remission of associated medical conditions. Complication rates are relatively high, underscoring careful patient selection is essential. Larger prospective studies focusing on elderly populations are warranted. Keypoints: MBS in elderly patients is effective in terms of weight loss and remission of associated medical complications. - MBS in elderly patients was associated with a relatively high complication rate. - Deaths within the study period were not associated with the MBS procedure.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Metabolic - Bariatric Surgery in Elderly Patients – Safety and Effectiveness in a Single-Center Cohort

  • Lea Pedarnig,
  • Julia Jedamzik,
  • Larissa Nixdorf,
  • Paula Richwien,
  • Magdalena Mairinger,
  • Christoph Bichler,
  • Felix Benedikt Langer,
  • Lisa Gensthaler,
  • Michael Krebs,
  • Gerhard Prager,
  • Daniel Moritz Felsenreich

摘要

Introduction

Overweight and obesity have been steadily increasing worldwide. Metabolic/bariatric surgery (MBS) is the most effective treatment for obesity and its associated medical conditions. Obesity complications increase with age, however, older patients face a higher perioperative risk necessitating a clear risk-benefit balance. This study evaluated weight-loss outcomes, remission of associated medical conditions, and complications in patients aged ≥ 65 years undergoing MBS.

Methods

This retrospective analysis included patients aged ≥ 65 years who underwent MBS at the Medical University of Vienna between 2008 and 2025. Weight and associated medical complications were assessed at baseline and at 1, 2, and 5 years postoperatively. Early (< 30 days) and late complications up to 5 years were recorded.

Results

In total, 111 patients were included. Baseline weight was 125.8 ± 22.3 kg and BMI 45.2 ± 7.4 kg/ \(\:{\text{m}}^{2}\) . At 5 years, mean BMI decreased to 27.5 ± 6.2 kg/ \(\:{\text{m}}^{2}\) corresponding to a total weight loss of 37.3 ± 14.7%. The prevalence of type II diabetes decreased from 54.1% to 22.9% and arterial hypertension from 87.4% to 56.2%. Early and late complications each occurred in 7.2%.

Conclusion

MBS achieves substantial long-term weight reduction and remission of associated medical conditions. Complication rates are relatively high, underscoring careful patient selection is essential. Larger prospective studies focusing on elderly populations are warranted. Keypoints: MBS in elderly patients is effective in terms of weight loss and remission of associated medical complications. - MBS in elderly patients was associated with a relatively high complication rate. - Deaths within the study period were not associated with the MBS procedure.